Vaccines for epidemic infections and the role of CEPI.
Identifieur interne : 001996 ( Ncbi/Merge ); précédent : 001995; suivant : 001997Vaccines for epidemic infections and the role of CEPI.
Auteurs : Stanley A. Plotkin [États-Unis]Source :
- Human vaccines & immunotherapeutics [ 2164-554X ] ; 2017.
Descripteurs français
- KwdFr :
- MESH :
- immunologie : Vaccins.
- isolement et purification : Vaccins.
- organisation et administration : Découverte de médicament.
- économie : Découverte de médicament.
- épidémiologie : Maladies transmissibles.
- Financement du capital, Humains, Épidémies.
English descriptors
- KwdEn :
- MESH :
- chemical , immunology : Vaccines.
- economics : Drug Discovery.
- epidemiology : Communicable Diseases.
- chemical , isolation & purification : Vaccines.
- organization & administration : Drug Discovery.
- prevention & control : Epidemics.
- Capital Financing, Humans.
Abstract
The author reviews the foundation of the Coalition for Epidemic Preparedness and Innovations and the choices it has made for funding of vaccine development against epidemic diseases. He comments on those decisions as well as proposing how CEPI could remain relevant for the long term.
DOI: 10.1080/21645515.2017.1306615
PubMed: 28375764
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000D35
- to stream PubMed, to step Curation: 000D35
- to stream PubMed, to step Checkpoint: 000A65
Links to Exploration step
pubmed:28375764Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vaccines for epidemic infections and the role of CEPI.</title><author><name sortKey="Plotkin, Stanley A" sort="Plotkin, Stanley A" uniqKey="Plotkin S" first="Stanley A" last="Plotkin">Stanley A. Plotkin</name><affiliation wicri:level="2"><nlm:affiliation>a Emeritus Professor of Pediatrics , University of Pennsylvania ; Vaxconsult, Doylestown , PA , USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>a Emeritus Professor of Pediatrics , University of Pennsylvania ; Vaxconsult, Doylestown , PA </wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28375764</idno><idno type="pmid">28375764</idno><idno type="doi">10.1080/21645515.2017.1306615</idno><idno type="wicri:Area/PubMed/Corpus">000D35</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D35</idno><idno type="wicri:Area/PubMed/Curation">000D35</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D35</idno><idno type="wicri:Area/PubMed/Checkpoint">000A65</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A65</idno><idno type="wicri:Area/Ncbi/Merge">001996</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Vaccines for epidemic infections and the role of CEPI.</title><author><name sortKey="Plotkin, Stanley A" sort="Plotkin, Stanley A" uniqKey="Plotkin S" first="Stanley A" last="Plotkin">Stanley A. Plotkin</name><affiliation wicri:level="2"><nlm:affiliation>a Emeritus Professor of Pediatrics , University of Pennsylvania ; Vaxconsult, Doylestown , PA , USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>a Emeritus Professor of Pediatrics , University of Pennsylvania ; Vaxconsult, Doylestown , PA </wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author></analytic><series><title level="j">Human vaccines & immunotherapeutics</title><idno type="eISSN">2164-554X</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Capital Financing</term><term>Communicable Diseases (epidemiology)</term><term>Drug Discovery (economics)</term><term>Drug Discovery (organization & administration)</term><term>Epidemics (prevention & control)</term><term>Humans</term><term>Vaccines (immunology)</term><term>Vaccines (isolation & purification)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Découverte de médicament (organisation et administration)</term><term>Découverte de médicament (économie)</term><term>Financement du capital</term><term>Humains</term><term>Maladies transmissibles (épidémiologie)</term><term>Vaccins (immunologie)</term><term>Vaccins (isolement et purification)</term><term>Épidémies ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Vaccines</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Drug Discovery</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Communicable Diseases</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Vaccines</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Vaccins</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Découverte de médicament</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Drug Discovery</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Epidemics</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Découverte de médicament</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Maladies transmissibles</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Capital Financing</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Financement du capital</term><term>Humains</term><term>Épidémies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The author reviews the foundation of the Coalition for Epidemic Preparedness and Innovations and the choices it has made for funding of vaccine development against epidemic diseases. He comments on those decisions as well as proposing how CEPI could remain relevant for the long term.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28375764</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2017</Year><Month>12</Month><Day>02</Day></PubDate></JournalIssue><Title>Human vaccines & immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Vaccines for epidemic infections and the role of CEPI.</ArticleTitle><Pagination><MedlinePgn>2755-2762</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2017.1306615</ELocationID><Abstract><AbstractText>The author reviews the foundation of the Coalition for Epidemic Preparedness and Innovations and the choices it has made for funding of vaccine development against epidemic diseases. He comments on those decisions as well as proposing how CEPI could remain relevant for the long term.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Plotkin</LastName><ForeName>Stanley A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>a Emeritus Professor of Pediatrics , University of Pennsylvania ; Vaxconsult, Doylestown , PA , USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002202" MajorTopicYN="N">Capital Financing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058872" MajorTopicYN="N">Epidemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">MERS</Keyword><Keyword MajorTopicYN="Y">Nipah</Keyword><Keyword MajorTopicYN="Y">chikungunya</Keyword><Keyword MajorTopicYN="Y">commercialization</Keyword><Keyword MajorTopicYN="Y">development</Keyword><Keyword MajorTopicYN="Y">ebola</Keyword><Keyword MajorTopicYN="Y">emerging infections</Keyword><Keyword MajorTopicYN="Y">field delivery</Keyword><Keyword MajorTopicYN="Y">infectious disease</Keyword><Keyword MajorTopicYN="Y">lassa</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28375764</ArticleId><ArticleId IdType="doi">10.1080/21645515.2017.1306615</ArticleId><ArticleId IdType="pmc">PMC5718831</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Int J Med Sci. 2014 May 14;11(7):732-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24904229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2015 May;15(5):519-27</Citation><ArticleIdList><ArticleId IdType="pubmed">25739878</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2013 Apr;12(4):379-93</Citation><ArticleIdList><ArticleId IdType="pubmed">23560919</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Aug 1;214(3):369-78</Citation><ArticleIdList><ArticleId IdType="pubmed">27001960</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2016 Mar 3;12 (3):716-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26554522</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2014 Jul 17;6(7):2735-61</Citation><ArticleIdList><ArticleId IdType="pubmed">25036462</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2014 Oct 21;32(46):6170-6176</Citation><ArticleIdList><ArticleId IdType="pubmed">25240756</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Jun 24;34(30):3525-34</Citation><ArticleIdList><ArticleId IdType="pubmed">27154393</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Dec 15;214(suppl 5):S488-S496</Citation><ArticleIdList><ArticleId IdType="pubmed">27920179</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2015 Sep 29;7(10):5172-90</Citation><ArticleIdList><ArticleId IdType="pubmed">26426036</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Dec 15;214(suppl 5):S497-S499</Citation><ArticleIdList><ArticleId IdType="pubmed">27920180</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Jun 3;34(26):2988-2991</Citation><ArticleIdList><ArticleId IdType="pubmed">27036511</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin. 2011 Jun;7(6):694-700</Citation><ArticleIdList><ArticleId IdType="pubmed">21451263</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2015 Jul;14(7):949-62</Citation><ArticleIdList><ArticleId IdType="pubmed">25864502</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2015 Oct 23;64(41):1171-6</Citation><ArticleIdList><ArticleId IdType="pubmed">26492381</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2015 Aug 19;7(301):301ra132</Citation><ArticleIdList><ArticleId IdType="pubmed">26290414</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2017 Apr;140:55-61</Citation><ArticleIdList><ArticleId IdType="pubmed">28040513</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Dec 15;214(suppl 5):S500-S505</Citation><ArticleIdList><ArticleId IdType="pubmed">27920181</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2015 May 07;9(5):e0003764</Citation><ArticleIdList><ArticleId IdType="pubmed">25951202</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Transl Med. 2015 Sep 30;7(307):307rv5</Citation><ArticleIdList><ArticleId IdType="pubmed">26424572</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2016;1426:297-309</Citation><ArticleIdList><ArticleId IdType="pubmed">27233282</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2016 Sep;15(9):1101-12</Citation><ArticleIdList><ArticleId IdType="pubmed">27160784</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2013 Sep;99(3):345-70</Citation><ArticleIdList><ArticleId IdType="pubmed">23811281</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Biol Sci. 2009 Nov 22;276(1675):3937-43</Citation><ArticleIdList><ArticleId IdType="pubmed">19692402</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2016 Nov;84:53-58</Citation><ArticleIdList><ArticleId IdType="pubmed">27721110</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2016 Dec 16;91(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">27795435</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jul 23;9(7):e102953</Citation><ArticleIdList><ArticleId IdType="pubmed">25054656</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 2005;18(2):317-26</Citation><ArticleIdList><ArticleId IdType="pubmed">16035943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2012 Dec 1;380(9857):1956-65</Citation><ArticleIdList><ArticleId IdType="pubmed">23200504</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Negl Trop Dis. 2015 Apr 17;9(4):e0003736</Citation><ArticleIdList><ArticleId IdType="pubmed">25884628</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2007 May 17;447(7142):279-83</Citation><ArticleIdList><ArticleId IdType="pubmed">17507975</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1999 Feb 4;397(6718):436-41</Citation><ArticleIdList><ArticleId IdType="pubmed">9989410</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Feb 16;376(7):610-613</Citation><ArticleIdList><ArticleId IdType="pubmed">28099066</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2012 Oct 29;4(11):2514-57</Citation><ArticleIdList><ArticleId IdType="pubmed">23202493</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2011 Nov;204 Suppl 3:S1075-81</Citation><ArticleIdList><ArticleId IdType="pubmed">21987744</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Trop Med Hyg. 2015 May;92(5):1006-12</Citation><ArticleIdList><ArticleId IdType="pubmed">25802426</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Jun 3;34(26):2976-2981</Citation><ArticleIdList><ArticleId IdType="pubmed">27026149</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2017 Jan 5;35(2):283-292</Citation><ArticleIdList><ArticleId IdType="pubmed">27919629</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2017 Feb;23 (2):192-199</Citation><ArticleIdList><ArticleId IdType="pubmed">27991917</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Jun 3;34(26):2992-2995</Citation><ArticleIdList><ArticleId IdType="pubmed">26973063</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):8871-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15951417</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1986 Jan 2;314(1):20-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3940312</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2015 Feb;135(2):e305-11</Citation><ArticleIdList><ArticleId IdType="pubmed">25583921</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2016 Dec;22(12 ):2037-2044</Citation><ArticleIdList><ArticleId IdType="pubmed">27869592</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Jun 3;34(26):2971-2975</Citation><ArticleIdList><ArticleId IdType="pubmed">26973068</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasite Immunol. 2016 Sep;38(9):535-47</Citation><ArticleIdList><ArticleId IdType="pubmed">27454991</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2015 Jul 2;205:1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">25997928</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull World Health Organ. 2016 Sep 1;94(9):675-686C</Citation><ArticleIdList><ArticleId IdType="pubmed">27708473</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2016 Oct 20;167(3):625-631</Citation><ArticleIdList><ArticleId IdType="pubmed">27693357</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2011 Aug 1;53(3):296-302</Citation><ArticleIdList><ArticleId IdType="pubmed">21765081</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Immunol. 2016 Dec;173:44-49</Citation><ArticleIdList><ArticleId IdType="pubmed">27910805</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Jun 3;34(26):2982-2987</Citation><ArticleIdList><ArticleId IdType="pubmed">27083424</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2016 Jan 1;351(6268):77-81</Citation><ArticleIdList><ArticleId IdType="pubmed">26678878</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Aug 11;29(35):5846-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21722688</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(3):e58414</Citation><ArticleIdList><ArticleId IdType="pubmed">23516477</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Virol. 2008 May;42(1):40-4</Citation><ArticleIdList><ArticleId IdType="pubmed">18164653</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Nov 15;214(10 ):1487-1491</Citation><ArticleIdList><ArticleId IdType="pubmed">27655868</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2014 Sep 12;345(6202):1369-72</Citation><ArticleIdList><ArticleId IdType="pubmed">25214632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2004 Nov;4(11):672-83</Citation><ArticleIdList><ArticleId IdType="pubmed">15522679</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2015 Jul 23;373(4):297-300</Citation><ArticleIdList><ArticleId IdType="pubmed">26200974</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2016 Aug;22(8):</Citation><ArticleIdList><ArticleId IdType="pubmed">27439020</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2010 Mar;16(3):334-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20111039</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2015 Jun 4;33(24):2823-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25865472</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Dec 15;214(suppl 5):S434-S435</Citation><ArticleIdList><ArticleId IdType="pubmed">27920168</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Res Int. 2015;2015:376230</Citation><ArticleIdList><ArticleId IdType="pubmed">25866777</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2016 Dec 15;214(suppl 5):S436-S440</Citation><ArticleIdList><ArticleId IdType="pubmed">27920169</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2017;1499:1-11</Citation><ArticleIdList><ArticleId IdType="pubmed">27987140</ArticleId></ArticleIdList></Reference><Reference><Citation>Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006841</Citation><ArticleIdList><ArticleId IdType="pubmed">22229120</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2017 Jan;137:82-92</Citation><ArticleIdList><ArticleId IdType="pubmed">27840203</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region></list><tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Plotkin, Stanley A" sort="Plotkin, Stanley A" uniqKey="Plotkin S" first="Stanley A" last="Plotkin">Stanley A. Plotkin</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001996 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001996 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:28375764
|texte= Vaccines for epidemic infections and the role of CEPI.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28375764" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |